Zimmer Competitors
| ZBH Stock | USD 96.43 0.02 0.02% |
Zimmer Biomet vs United Therapeutics Correlation
Modest diversification
The correlation between Zimmer Biomet Holdings and UTHR is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zimmer Biomet Holdings and UTHR in the same portfolio, assuming nothing else is changed.
Moving against Zimmer Stock
| 0.62 | ECOR | Electrocore LLC | PairCorr |
| 0.54 | SKAN | SKAN Group AG | PairCorr |
| 0.46 | VREX | Varex Imaging Corp | PairCorr |
| 0.32 | OM | Outset Medical | PairCorr |
| 0.32 | DXCM | DexCom Inc | PairCorr |
Zimmer Biomet Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Zimmer Biomet and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Zimmer and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Zimmer Biomet Holdings does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Zimmer Stock performing well and Zimmer Biomet Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zimmer Biomet's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SNN | 1.00 | 0.09 | 0.05 | 0.23 | 1.26 | 2.29 | 8.41 | |||
| DGX | 1.13 | 0.18 | 0.11 | 1.17 | 0.96 | 2.75 | 8.55 | |||
| STE | 1.03 | (0.15) | 0.00 | (0.08) | 0.00 | 1.79 | 10.43 | |||
| WAT | 1.23 | (0.28) | 0.00 | (0.19) | 0.00 | 3.25 | 18.00 | |||
| ILMN | 1.85 | (0.05) | 0.00 | (0.20) | 0.00 | 3.85 | 15.59 | |||
| WST | 1.59 | (0.23) | 0.00 | (0.08) | 0.00 | 2.82 | 12.18 | |||
| DXCM | 1.47 | 0.33 | 0.18 | 0.46 | 1.29 | 3.31 | 10.50 | |||
| INCY | 1.63 | (0.12) | 0.00 | (0.05) | 0.00 | 4.10 | 13.76 | |||
| LH | 1.03 | 0.09 | 0.05 | 0.24 | 1.16 | 2.71 | 7.89 | |||
| UTHR | 0.96 | 0.04 | 0.00 | 0.19 | 1.16 | 1.94 | 5.21 |
Cross Equities Net Income Analysis
Compare Zimmer Biomet Holdings and related stocks such as Smith Nephew SNATS, Quest Diagnostics, and STERIS plc Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNN | 68.4 M | 582 M | 729 M | 556 M | 501 M | 410 M | 784 M | 767 M | 663 M | 600 M | 448 M | 524 M | 223 M | 263 M | 412 M | 473.8 M | 371.1 M |
| DGX | (626 M) | 470.6 M | 555.7 M | 849 M | 556 M | 709 M | 645 M | 772 M | 736 M | 858 M | 1.4 B | 2 B | 946 M | 854 M | 871 M | 992 M | 646.9 M |
| STE | 2.5 M | 136.1 M | 160 M | 129.4 M | 135.1 M | 110.8 M | 110 M | 290.9 M | 304.1 M | 407.7 M | 397.4 M | 243.9 M | 107 M | 378.2 M | 614.6 M | 706.8 M | 742.2 M |
| WAT | 2 M | 433 M | 461.4 M | 450 M | 431.6 M | 469.1 M | 521.5 M | 20.3 M | 593.8 M | 592.2 M | 521.6 M | 692.8 M | 707.8 M | 642.2 M | 637.8 M | 642.6 M | 373.6 M |
| ILMN | (5.5 M) | 86.6 M | 151.3 M | 125.3 M | 353.4 M | 461.6 M | 462.6 M | 726 M | 826 M | 1 B | 656 M | 762 M | (4.4 B) | (1.2 B) | (1.2 B) | 850 M | 892.5 M |
| WST | 15 M | 75.5 M | 80.7 M | 112.3 M | 127.1 M | 95.6 M | 143.6 M | 150.7 M | 206.9 M | 241.7 M | 346.2 M | 661.8 M | 585.9 M | 593.4 M | 492.7 M | 493.7 M | 518.4 M |
| DXCM | (4 M) | (44.7 M) | (54.5 M) | (29.8 M) | (22.4 M) | (57.6 M) | (65.6 M) | (50.2 M) | (127.1 M) | 101.1 M | 493.6 M | 216.9 M | 341.2 M | 541.5 M | 576.2 M | 836.3 M | 878.1 M |
| INCY | (4.9 M) | (186.5 M) | (44.3 M) | (83.1 M) | (48.5 M) | 6.5 M | 104.2 M | (313.1 M) | 109.5 M | 446.9 M | (295.7 M) | 948.6 M | 340.7 M | 597.6 M | 32.6 M | 1.3 B | 1.4 B |
| LH | 49.1 M | 519.7 M | 583.1 M | 573.8 M | 511.2 M | 436.9 M | 732.1 M | 1.3 B | 883.7 M | 823.8 M | 1.6 B | 2.4 B | 1.3 B | 418 M | 746 M | 857.9 M | 509.7 M |
| UTHR | (12.8 M) | 217.9 M | 304.4 M | 174.6 M | 340.1 M | 651.6 M | 713.7 M | 417.9 M | 589.2 M | (104.5 M) | 514.8 M | 475.8 M | 727.3 M | 984.8 M | 1.2 B | 1.4 B | 1.4 B |
Zimmer Biomet Holdings and related stocks such as Smith Nephew SNATS, Quest Diagnostics, and STERIS plc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Zimmer Biomet Holdings financial statement analysis. It represents the amount of money remaining after all of Zimmer Biomet Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Zimmer Biomet Competitive Analysis
The better you understand Zimmer Biomet competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Zimmer Biomet's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Zimmer Biomet's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Zimmer Biomet Competition Performance Charts
Five steps to successful analysis of Zimmer Biomet Competition
Zimmer Biomet's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Zimmer Biomet Holdings in relation to its competition. Zimmer Biomet's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Zimmer Biomet in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Zimmer Biomet's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Zimmer Biomet Holdings, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Zimmer Biomet position
In addition to having Zimmer Biomet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Size And Style ETFs Thematic Idea Now
Size And Style ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Size And Style ETFs theme has 1429 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Size And Style ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Zimmer Biomet Correlation with its peers. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.41) | Dividend Share 0.96 | Earnings Share 3.55 | Revenue Per Share | Quarterly Revenue Growth 0.109 |
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.